It seems a little last century to talk about AI medicine in the future tense since 3D X-ray, age battling drugs and curing cancer using HIV virus are all taking place now.

Although there are still 70% of us fearing AI and robot “could spell the end of human race” and Luddites may appear again (perhaps in another form, like data breach), it’s more practical for us to ponder ways which we can better work along with our non-human counterparts.

Indeed AI is able to process a large amount of data at once and unlock the valuable information embedded within. However, medical data is not collected systematically, often, they are not available, even if it is, there is a need to overcome ownership issue before they are legally and ethically employed for future use.

Medicine cannot do away with safety and efficiency, hence, reliability and security concerns posed by AI, will be the greatest hurdle the sector needs to overcome.

Furthermore, AI has rendered us numerous opportunities but unlike driverless cars and digital personal assistants, there is no drug successfully developed by AI or a hospital solely run by robots yet. While we recognized that AI medicine’s future is today, there is still a lot we can anticipate tomorrow.

Most importantly, as compared to AI, AE or artificial empathy is a less venture area. Presently, companion robots are trained to identify and process human emotions and to show sympathy when required but this skill is less heard of for other forms of AI. While AI may be able to cure but they are not able to care, thus our worry should AI becoming paperclip maximiser rather than taking over human physicians.

Maybe it’s time for us to listen to experts and their views on this.

Learn more about this topic at AIMed North America, register here.

Session Focus: Future Aspects of AI in medicine

When: Saturday, December 15th 2018 (10.30-11.30)

On the last day of this year’s AI med North America, tech tycoons and academia are going to spell us the future of AI medicine: its developments, collaborations, and challenges.

Attendees will gain the following knowledge:

Find out if now is the future of AI medicine and what else are out there for us to get excited about?

Insights into the challenges that AI medicine is still facing today and probably tomorrow.

Discover when is the right time to get on board; AI medicine still renders a large room for enthusiasts but what are they?

Benefit from experts’ views and interactions with others who have the same in mind.


Sean Lane, CEO, Olive AI, USA

Timothy Chou, Author and Lecturer, Stanford University, USA

Jesse Ehrenfeld, Chair-elect, AMA Board of Trustees, USA

Steven Small, Professor and Chair of Neurology, University of California, Irvine, USA

Tom Murickan, Founder, AI-MED Club Diamond Bar High School

Learn more about this topic at AIMed North America, register here.